Search results
Filter by type
Line of business
Category
Filter by date
10 of 54 results
Medicare covers the routine costs of qualifying clinical trials, as such costs are defined in National Coverage Determination (NCD) 310.1, as well as reasonable and necessary items and services used to diagnose and treat complications arisi…
General information regarding proposed LCDs and open meetings.
View the must updated information on the process for requesting a new LCD.
Requirements for IDEs approved by CMS.
Join First Coast's Contractor Advisory Committee (CAC) to provide your input during the development process of LCDs.
View CAC meeting minutes from our meeting on February 19, 2026, on the use of urine-based biomarkers in patients with microhematuria.
View these billing and coding instructions of routine costs for qualifying clinical trials.
Read about pre-market approval (PMA), PMA post-approval studies, pre-market notification (PMN) 510(k), and 510(k) post-approval extension studies guidelines related only to percutaneous transluminal angioplasty (PTA) with carotid artery ste…
View these reasons why First Coast may consider retiring LCDs and articles.
View these guidelines regarding what it means for a service to be "reasonable and necessary."